Skip to main content

stock

SION · Sionna Therapeutics, Inc.

What Sionna Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live SION price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on SION.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
45,212,399 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-36.6%
ROA
-34.4%

Health

Current ratio
20.0x
Debt/equity
—

Deep value

NCAV
$198.66M
NCAV per share
$4.39
Price/NCAV
Locked
NNWC
$45.85M
NNWC per share
$1.01
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$32.47M-$29.89M
10-Q filed 2026-08-06
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$29.60M-$26.78M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$23.61M-$20.44M
10-K filed 2026-03-02
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$23.80M-$20.28M
10-Q filed 2025-11-05
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$21.91M-$18.07M
10-Q filed 2026-08-06
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$19.66M-$16.48M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$18.13M-$15.85M
10-K filed 2026-03-02
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$27.98M-$25.44M
10-Q filed 2025-11-05
Assets
$283.25M
Equity
$265.77M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$88.98M-$75.27M-$66.67M
2024-12-31—-$70.56M-$61.69M-$52.81M

Company filings

since Mon Mar 2

events

  • Exit or restructuring costs, Executive or director change, Other event

    Exit or restructuring costsExecutive or director changeOther event
    Sep 148-K
  • Other event

    Other event
    Aug 108-K
  • Results

    Results
    Aug 68-K
  • Shareholder vote results

    Shareholder vote results
    Jun 188-K
  • Results

    Results
    May 128-K
  • Results

    Results
    Mar 28-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • RA CAPITAL MANAGEMENT, L.P.

    Director, 10% owner

    Sale$21,835,018

    Sep 21, 6:56 PM ET

  • Thompson Peter A.

    Director

    Sale$3,854,281

    Jul 9, 4:47 PM ET

  • ORBIMED ADVISORS LLC

    Director

    Sale$3,854,281

    Jul 9, 4:44 PM ET

All insider trades for SION

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

All funds

News

Stories that named SION, and the market events around them.

Sign in to see this

Board

The SION board could not be loaded.

Retry the SION board

nakagai

Signals on SION come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the SION board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Sionna Therapeutics, Inc. (SION): SEC filings, financials and insider trades · Nakagai